EphA4 Mediates Pro- and Anti- Tumoral Effects Through Upstream Negative Regulation of AKT in Head and Neck Squamous Cell Carcinoma

scRNA data for peripheral blood mononuclear cells (PBMCs) from oral cavity squamous cell carcinoma patients were generated by sequencing with a 10x Genomics fixed scRNA kit (Flex) (RRID:SCR_022938) with raw data processed with 10x Genomics cellranger (RRID:SCR_017344). PBMC samples were obtained from Oliva M, et al., Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study. J Immunother Cancer. 2021 Oct;9(10):e003476. doi: 10.1136/jitc-2021-003476. PMID: 34599023; PMCID: PMC8488751. Pre represents samples collected before treatment, and Dis represents samples collected after Sitravatinib treatment. Sitravatinib was administered as an oral capsule once daily at a dose of 120 mg. For metadata, please see the paper referenced above.